Tilray Brands (NASDAQ:TLRY) Stock Price Up 1.8% - Here's Why

Key Points

• Tilray Brands shares rose 1.8% in midday trading, with the stock hitting an intraday high of $5.71 before last trading at $5.65. Volume was slightly below average.
• The company announced a new premium cannabis launch under its Broken Coast brand, rolling out Cherry Ztripez flower and pre-rolls for summer. The move fits Tilray’s strategy to strengthen its premium product lineup and support revenue growth.
• Despite the day’s gain, Tilray remains under pressure: recent commentary says the stock has fallen sharply השנה, and analysts continue to see meaningful upside depending on U.S. cannabis reform, which is still uncertain. Current analyst sentiment is mixed, with an overall Hold rating and average price target of $11.50.

Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) shares rose 1.8% during mid-day trading on Thursday . The company traded as high as $5.71 and last traded at $5.65. Approximately 4,280,655 shares changed hands during trading, a decline of 3% from the average daily volume of 4,410,574 shares. The stock had previously closed at $5.55.

More Tilray Brands News

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray announced a new premium cannabis launch from its Broken Coast brand, introducing Cherry Ztripez flower and pre-rolls for summer. The rollout supports its premium product strategy and could help revenue and brand momentum. Article Title
• Positive Sentiment: A sector article flagged TLRY as one of the top Canadian marijuana stocks to watch, citing long-term industry potential, international expansion, improving operational efficiency, and possible U.S. cannabis reform as catalysts. Article Title
• Neutral Sentiment: Short-interest data showed no reported short interest change, offering little new trading signal for investors. Article Title
• Negative Sentiment: Recent commentary noted that Tilray’s stock has fallen sharply this year and remains under pressure, reflecting persistent concerns about the company’s fundamentals and the pace of any recovery. Article Title
• Negative Sentiment: Analysts and media coverage continue to emphasize that a meaningful breakout likely depends on U.S. federal cannabis reform, which remains uncertain and limits near-term upside. Article Title

Analysts Set New Price Targets

TLRY has been the topic of a number of recent research reports. Zacks Research raised Tilray Brands from a "strong sell" rating to a "hold" rating in a report on Wednesday, February 11th. ATB Cormark Capital Markets decreased their target price on Tilray Brands from $9.50 to $9.00 and set a "sector perform" rating on the stock in a research note on Thursday, April 2nd. TD Cowen decreased their target price on Tilray Brands from $10.00 to $7.00 and set a "buy" rating on the stock in a research note on Monday, March 30th. Weiss Ratings lowered Tilray Brands from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Wednesday, May 13th. Finally, Wall Street Zen upgraded Tilray Brands from a "sell" rating to a "hold" rating in a research note on Saturday, March 21st. Three analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Tilray Brands presently has an average rating of "Hold" and an average price target of $11.50.

Tilray Brands Price Performance

The firm has a market capitalization of $658.51 million, a P/E ratio of -0.41 and a beta of 1.94. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79. The business has a 50 day simple moving average of $6.25 and a two-hundred day simple moving average of $7.97.

Tilray Brands (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The firm had revenue of $206.73 million for the quarter, compared to the consensus estimate of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same quarter last year, the company posted ($0.87) earnings per share. On average, sell-side analysts expect that Tilray Brands, Inc. will post -0.58 EPS for the current fiscal year.

Insider Activity at Tilray Brands

In other news, Director David G. Hopkinson sold 33,556 shares of the stock in a transaction dated Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total transaction of $232,878.64. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.84% of the company's stock.

Hedge Funds Weigh In On Tilray Brands

Several institutional investors have recently modified their holdings of the company. Hilton Head Capital Partners LLC bought a new position in shares of Tilray Brands during the 4th quarter valued at about $38,000. Pictet Asset Management Holding SA increased its position in shares of Tilray Brands by 38.9% during the 1st quarter. Pictet Asset Management Holding SA now owns 18,387 shares of the company's stock valued at $119,000 after purchasing an additional 5,145 shares during the last quarter. Schonfeld Strategic Advisors LLC increased its position in shares of Tilray Brands by 4.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company's stock valued at $1,304,000 after purchasing an additional 6,182 shares during the last quarter. Baader Bank Aktiengesellschaft increased its position in shares of Tilray Brands by 17.7% during the 1st quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company's stock valued at $293,000 after purchasing an additional 7,226 shares during the last quarter. Finally, IFP Advisors Inc increased its position in shares of Tilray Brands by 14.3% during the 4th quarter. IFP Advisors Inc now owns 60,318 shares of the company's stock valued at $545,000 after purchasing an additional 7,541 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.